TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 308 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -10.0% | 767 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | 0.0% | 767 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -41.2% | 767 | -40.5% | 0.00% | -40.0% |
| Q4 2021 | $17,000 | -19.0% | 1,288 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $21,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $21,000 | -8.7% | 1,288 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $23,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $23,000 | +4.5% | 1,288 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $22,000 | -4.3% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $23,000 | +21.1% | 1,288 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $19,000 | -24.0% | 1,288 | 0.0% | 0.01% | -12.5% |
| Q4 2019 | $25,000 | +13.6% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $22,000 | 0.0% | 1,288 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $22,000 | -15.4% | 1,288 | 0.0% | 0.01% | -11.1% |
| Q1 2019 | $26,000 | – | 1,288 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 8,958,784 | $176,757,000 | 33.75% |
| Ovata Capital Management Ltd | 879,800 | $17,557,092,000 | 13.04% |
| Paulson & Co. | 13,244,711 | $261,318,000 | 5.64% |
| Glenview Capital Management | 30,582,721 | $603,397,000 | 5.28% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 718,028 | $14,167,000 | 4.85% |
| Velanne Asset Management Ltd | 302,694 | $5,972,000 | 3.52% |
| Blackcrane Capital, LLC | 172,708 | $3,408,000 | 2.72% |
| Melqart Asset Management (UK) Ltd | 1,557,000 | $30,720,000 | 2.57% |
| GMT CAPITAL CORP | 3,345,976 | $66,016,000 | 2.55% |
| REDWOOD CAPITAL MANAGEMENT, LLC | 827,955 | $16,336,000 | 2.24% |